Fund Holdings — Lynx1 Capital Management LP

Total Portfolio Value:
$632.72M
Total Bought:
$129.11M
Total Sold:
$35.67M
Net Transaction:
+$93.44M
Notable People:
Weston Agnew Nichols
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Stoke Therapeutics, Inc.(STOK)5,404,6744,763,673-641,001$171.54M$155.11M24.51%-$16.44M
GH Research PLC(GHRS)10,406,57510,763,288+356,713$132.16M$151.33M23.92%+$19.17M
Cullinan Therapeutics, Inc.(CGEM)8,963,5008,963,5000$92.77M$127.37M20.13%+$34.60M
Agios Pharmaceuticals, Inc.(AGIO)79,6242,611,568+2,531,944$2.17M$88.35M13.96%+$86.18M
Denali Therapeutics Inc.(DNLI)1,738,7501,880,303+141,553$28.71M$36.10M5.71%+$7.40M
C4 Therapeutics, Inc.(CCCC)7,098,1336,998,902-99,231$13.56M$18.41M2.91%+$4.85M
Korro Bio, Inc.(KRRO)677,9151,538,296+860,381$5.43M$17.41M2.75%+$11.98M
TScan Therapeutics, Inc.(TCRX)8,019,1488,019,1480$8.02M$8.10M1.28%+$80.2K
Xencor, Inc.(XNCR)705,558536,398-169,160$10.80M$6.47M1.02%-$4.33M
Precision BioSciences, Inc.(DTIL)993,913985,113-8,800$4.13M$5.42M0.86%+$1.28M
Passage Bio, Inc.(PASG)623,704623,7040$7.36M$4.90M0.77%-$2.46M
Neuphoria Therapeutics Inc875,228875,328+100$3.40M$3.56M0.56%+$166.7K
Entrada Therapeutics, Inc.(TRDA)51,689211,689+160,000$531.4K$2.67M0.42%+$2.14M
CG Oncology, Inc.(CGON)31,59131,5910$1.31M$2.14M0.34%+$826.4K
Immatics N.V.SHS(IMTX)921,950216,973-704,977$9.68M$2.14M0.34%-$7.55M
Design Therapeutics, Inc.(DSGN)69,516119,516+50,000$652.1K$1.27M0.20%+$619.6K
Yarrow Bioscience Inc(YARW)01,628,700+1,628,700$0$973.1K0.15%+$973.1K
Werewolf Therapeutics, Inc.(HOWL)655,926657,786+1,860$415.5K$547.7K0.09%+$132.1K
iBio, Inc.(IBIO)068,076+68,076$0$129.3K0.02%+$129.3K
Bolt Biotherapeutics Inc030,800+30,800$0$124.4K0.02%+$124.4K
Proqr Thrapeutics N VSHS EURO
SHS EURO
68,48668,4860$138.3K$110.9K0.02%-$27.4K
Absci Corporation021,245+21,245$0$63.7K0.01%+$63.7K
Traws Pharma, Inc.(TRAW)015,078+15,078$0$27.6K0.00%+$27.6K
Applied Therapeutics Inc410,5000-410,500$41.0K$0—-$41.0K
Arrowhead Pharmaceuticals, Inc.(ARWR)12,0430-12,043$799.5K$0—-$799.5K
Generation Bio Co25,0000-25,000$142.0K$0—-$142.0K
MapLight Therapeutics, Inc.(MPLT)13,4770-13,477$236.7K$0—-$236.7K
Page 1 of 1
Lynx1 Capital Management LP — 13F Holdings — Q1 2026 | TickerTrail